DEVELOPMENTAL FUNDS: ABSTRACT Developmental Funds of $50,000 are requested to provide an essential foundation of support for the Cancer Center's investment in emerging scientific and technological opportunities. As part of the planning and evaluation process, KCI links its strategic objectives with programmatic priorities and targets funding to specific developmental goals in: 1) support of innovative pilot projects; 2) recruitment of faculty-level scientists; 3) development of programs that train researchers and sustain a vigorous portfolio of external funding; 4) support of developing Shared Resources; and 5) providing Core vouchers that encourage the use of Cancer Center Shared Resources by junior faculty and those wishing to explore innovative, otherwise unfunded research. CCSG Developmental Funds During the period of 12/1/2010 to 5/31/2014, three developing Shared Resources were supported with $187,372 of CCSG Developmental Funds: Animal Model and Therapeutics Evaluation Core (AMTEC), Translational Sciences Core (TSC), and Clinical Imaging Research Core (CIRC). The AMTEC developing Core is being submitted as a new, full Core in this competing renewal application. The TSC developing Core is being integrated into the Biorepository Core (which has been re-named Biobanking and Correlative Sciences Core). The CIRC has been discontinued as a developing Core with the concurrence of our EAB. WSU/KCI Institutional Support for Developmental Fund Activities During the period of 12/1/2010 to 5/31/2014, institutional support provided a total of $11.5 million in funds. With the use of these funds, the Cancer Center has achieved a remarkable return on investment: ? Investing in annual pilot funding for innovative projects. A total of $985,232 was invested in pilot projects, yielding eleven extramural awards, totaling $9,989,542. ? Supporting the recruitment of faculty level scientists. A total of $7,918,013 was provided from a combination of KCI and WSU institutional support for 42 new faculty members' salaries and lab support during the past three-and-a-half years. These new faculty level scientists have generated a total of 211 publications, 32 grant awards, and 85 clinical trials since their arrival. ? Establishing a post-doctoral research training program. A total of $215,908 supported 8 post-doctoral fellows, resulting in the recruitment of one faculty level scientist. ? Creating a mock study section program. A total of $5,400 in stipends to reviewers was provided from institutional support, resulting in $1,580,044 of extramural funding. ? Nurturing three new Shared Resources. A total of $2,330,214 was provided from institutional support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-36
Application #
9384723
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
36
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications